
Anderson TK, Chang J, Arendsee ZW, Venkatesh D, Souza CK, Kimble JB, et al. Swine influenza A viruses and the tangled relationship with humans. Cold Spring Harb Perspect Med. 2021;11:a038737.
Nelson MI, Schaefer R, Gava D, Cantão ME, Ciacci-Zanella JR. Influenza A viruses of human origin in swine. Brazil Emerg Infect Dis. 2015;21:1339–47.
Tochetto C, Junqueira DM, Anderson TK, Gava D, Haach V, Cantão ME, et al. Introductions of human-origin seasonal H3N2, H1N2 and pre-2009 H1N1 influenza viruses to swine in Brazil. Viruses. 2023;15:576.
Junqueira DM, Tochetto C, Anderson TK, Gava D, Haach V, Cantão ME, Baker ALV, Schaefer R, Human-to-swine introductions and onward transmission of 2009 H1N1 pandemic influenza viruses in Brazil. Front Microbiol. 2023;14:1243567.
Schaefer R, Lopes S, Gava D, Ciacci-Zanella JR, Anderson TK, Lewis NS, et al. Genetic and antigenic diversity of contemporary influenza A virus in swine in Brazil. Proc Int Pig Vet Soc Congr. Rio de Janeiro; 2020. p. 828.
Rajão DS, Walia RR, Campbell B, Gauger PC, Janas-Martindale A, Killian ML, et al. Reassortment between swine H3N2 and 2009 pandemic H1N1 in the United States resulted in influenza A viruses with diverse genetic constellations with variable virulence in pigs. J Virol. 2017;91:e01763-e1816.
Krammer F. The human antibody response to influenza A virus infection and vaccination. Nat Rev Immunol. 2019;19:383–97.
Koel BF, Mögling R, Chutinimitkul S, Fraaij PL, Burke DF, van der Vliet S, et al. Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses. J Virol. 2015;89:3763–75.
Vincent AL, Perez DR, Rajao D, Anderson TK, Abente EJ, Walia RR, et al. Influenza A virus vaccines for swine. Vet Microbiol. 2017;206:35–44.
Mancera Gracia JC, Pearce DS, Masic A, Balasch M. Influenza A virus in swine: epidemiology, challenges and vaccination strategies. Front Vet Sci. 2020;7:647.
Van Reeth K, Ma W. Swine influenza virus vaccines: to change or not to change—that’s the question. Curr Top Microbiol Immunol. 2013;370:173–200.
Kappes MA, Sandbulte MR, Platt R, Wang C, Lager KM, Henningson JN, et al. Vaccination with NS1-truncated H3N2 swine influenza virus primes T cells and confers cross-protection against an H1N1 heterosubtypic challenge in pigs. Vaccine. 2012;30:280–8.
Sharma A, Zeller MA, Li G, Harmon KM, Zhang J, Hoang H, et al. Detection of live attenuated influenza vaccine virus and evidence of reassortment in the U.S. swine population. J Vet Diagnostic Investig. 2020;32:301–11.
Braucher DR, Henningson JN, Loving CL, Vincen AL, Kim E, Steitz J, et al. Intranasal vaccination with replication-defective adenovirus type 5 encoding influenza virus hemagglutinin elicits protective immunity to homologous challenge and partial protection to heterologous challenge in pigs. Clin Vaccine Immunol. 2012;19:1722–9.
Joshi LR, Knudsen D, Piñeyro P, Dhakal S, Renukaradhya GJ, Diel DG. Protective efficacy of an orf virus-vector encoding the hemagglutinin and the nucleoprotein of influenza A virus in swine. Front Immunol. 2021;12:747574.
Borggren M, Nielsen J, Karlsson I, Dalgaard TS, Trebbien R, Williams JA, et al. A polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs. Vaccine. 2016;34:3634–40.
Hernandez LA, Miller CL, Vaughn EM. Particle and subunit-based hemagglutinin vaccines provide protective efficacy against H1N1 influenza in pigs. Vet Microbiol. 2016;191:35–43.
Soema PC, Kompier R, Amorij JP, Kersten GFA. Current and next generation influenza vaccines: formulation and production strategies. Eur J Pharm Biopharm. 2015;94:251–63.
Huckriede A, Bungener L, Stegmann T, Daemen T, Medema J, Palache AM, et al. The virosome concept for influenza vaccines. Vaccine. 2005;23:S38.
Wilschut J. Influenza vaccines: the virosome concept. Immunol Lett. 2009;122:118–21.
Herzog C, Hartmann K, Künzi V, Kürsteiner O, Mischler R, Lazar H, et al. Eleven years of Inflexal® V-a virosomal adjuvanted influenza vaccine. Vaccine. 2009;27:4381–7.
Mallick AI, Parvizi P, Read LR, Nagy É, Behboudi S, Sharif S. Enhancement of immunogenicity of a virosome-based avian influenza vaccine in chickens by incorporating CpG-ODN. Vaccine. 2011;29:1657–65.
Zhang J, Gauger PC. Isolation of swine influenza A virus in cell cultures and embryonated chicken eggs. Methods Mol Biol. 2020;2123:281–94.
Fonseca F, Haach V, Bellaver F, Bombassaro G, Gava D, Paulino L, et al. Immunological profile of mice immunized with a polyvalent virosome-based influenza vaccine. Preprint at https://doi.org/10.21203/rs.3.rs-2923914/v1 (2023).
Zhang J, Harmon KM. RNA extraction from swine samples and detection of influenza A virus in swine by real-time RT-PCR. Methods Mol Biol. 2020;2123:295–310.
Lager KM, Vincent AL. In vivo models for pathotyping and vaccine efficacy for swine influenza. Methods Mol Biol. 2020;2123:345–51.
Opriessnig T, Yu S, Gallup JM, Evans RB, Fenaux M, Pallares F, et al. Effect of vaccination with selective bacterins on conventional pigs infected with type 2 porcine circovirus. Vet Pathol. 2003;40:521–9.
Schaller A, Djordjevic SP, Eamens GJ, Forbes WA, Kuhn R, Kuhnert P, et al. Identification and detection of Actinobacillus pleuropneumoniae by PCR based on the gene apxIVA. Vet Microbiol. 2001;79:47–62.
Turni C, Pyke M, Blackall PJ. Validation of a real-time PCR for Haemophilus parasuis. J Appl Microbiol. 2010;108:1323–31.
Dubosson CR, Conzelmann C, Miserez R, Boerlin P, Frey J, Zimmermann W, et al. Development of two real-time PCR assays for the detection of Mycoplasma hyopneumoniae in clinical samples. Vet Microbiol. 2004;102:55–65.
Townsend KM, Boyce JD, Chung JY, Frost AJ, Adler B. Genetic organization of Pasteurella multocida cap loci and development of a multiplex capsular PCR typing system. J Clin Microbiol. 2001;39:924–9.
Gava D, Caron L, Schaefer R, Silva VS, Weiblen R, Flores EF, et al. A retrospective study of porcine reproductive and respiratory syndrome virus infection in Brazilian pigs from 2008 to 2020. Transbound Emerg Dis. 2022;69:903–7.
Prophet EB, Mills B, Arrington JB, Sobin LH. Laboratory Methods in Histotechnology. Washington: Armed Forces Institute of Pathology; 1992.
Gava D, Zanella EL, Morés N, Ciacci-Zanella JR. Transmission of porcine circovirus 2 (PCV2) by semen and viral distribution in different piglet tissues. Pesqui Veterinária Bras. 2008;28:70–6.
Kitikoon P, Gauger PC, Vincent AL. Hemagglutinin inhibition assay with swine sera. Methods Mol Biol. 2014;1161:295–301.
Gauger PC, Vincent AL. Serum virus neutralization assay for detection and quantitation of serum-neutralizing antibodies to influenza A virus in swine. Methods Mol Biol. 2014;1161:313–24.
Dawson HD, Lunney JK. Porcine cluster of differentiation (CD) markers 2018 update. Res Vet Sci. 2018;118:199–246.
Maciag SS, Bellaver FV, Bombassaro G, Haach V, Morés MAZ, Baron LF, et al. On the influence of the source of porcine colostrum in the development of early immune ontogeny in piglets. Sci Rep. 2022;12:15630.
SAS. System for Microsoft Windows. Cary, NC, USA; 2012.
Rajão DS, Costa ATR, Brasil BSAF, Del Puerto HL, Oliveira FG, Alves F, et al. Genetic characterization of influenza virus circulating in Brazilian pigs during 2009 and 2010 reveals a high prevalence of the pandemic H1N1 subtype. Influenza Other Respi Viruses. 2013;7:783–90.
Schaefer R, Rech RR, Gava D, Cantão ME, da Silva MC, Silveira S, et al. A human-like H1N2 influenza virus detected during an outbreak of acute respiratory disease in swine in Brazil. Arch Virol. 2015;160:29–38.
Resende PC, Born PS, Matos AR, Motta FC, Caetano BC, Debur M do C, et al. Whole-genome characterization of a novel human influenza A(H1N2) virus variant, Brazil. Emerg Infect Dis. 2017;23:152–4.
Schaefer R, Zanella JRC, Brentano L, Vincen AL, Ritterbusc GA, Silveira S, et al. Isolation and characterization of a pandemic H1N1 influenza virus in pigs in Brazil. Pesqui Veterinária Bras. 2011;31.
Kammer AR, Amacker M, Rasi S, Westerfeld N, Gremion C, Neuhaus D, et al. A new and versatile virosomal antigen delivery system to induce cellular and humoral immune responses. Vaccine. 2007;25:7065–74.
Lambkin R, Oxford JS, Bossuyt S, Mann A, Metcalfe IC, Herzog C, et al. Strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccine. Vaccine. 2004;22:4390–6.
Rasool MH, Mehmood A, Saqalein M, Nisar MA, Almatroudi A, Khurshid M. Development, biological characterization, and immunological evaluation of virosome vaccine against Newcastle disease in Pakistan. Biomed Res Int. 2021.
Kapczynski DR. Development of a virosome vaccine against avian metapneumovirus subtype C for protection in turkeys. Avian Dis. 2004;48:332–43.
van der Velden YU, Grobben M, Caniels TG, Burger JA, Poniman M, Oomen M, et al. A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike. Sci Rep. 2022;12:3884.
Van Der Wielen M, Vertruyen A, Froesner G, Ibáñez R, Hunt M, Herzog C, et al. Immunogenicity and safety of a pediatric dose of a virosome-adjuvanted hepatitis A vaccine: a controlled trial in children aged 1–16 years. Pediatr Infect Dis J. 2007;26:705–10.
Glück R, Mischler R, Finkel B, Que JU, Cryz SJ, Scarpa B. Immunogenicity of new virosome influenza vaccine in elderly people. Lancet. 1994;344:160–3.
Sicca F, Neppelenbroek S, Huckriede A. Effector mechanisms of influenza-specific antibodies: neutralization and beyond. Expert Rev Vaccines. 2018;17:785–95.
Waffarn EE, Baumgarth N. Protective B cell responses to flu—no fluke! J Immunol. 2011;186:3823–9.
Van Reeth K, Labarque G, Pensaert M. Serological profiles after consecutive experimental infections of pigs with European H1N1, H3N2, and H1N2 swine influenza viruses. Viral Immunol. 2006;19:373–82.
Van Reeth K, Gregory V, Hay A, Pensaert M. Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes. Vaccine. 2003;21:1375–81.
Schmidt ME, Varga SM. The CD8 T cell response to respiratory virus infections. Front Immunol. 2018;9:678.
De Bruin TGM, Van Rooij EMA, De Visser YE, Bianchi ATJ. Cytolytic function for pseudorabies virus-stimulated porcine CD4+ CD8dull+ lymphocytes. Viral Immunol. 2000;13:511–20.
Denyer MS, Wileman TE, Stirling CMA, Zuber B, Takamatsu HH. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells. Vet Immunol Immunopathol. 2006;110:279–92.
Cullen JG, McQuilten HA, Quinn KM, Olshansky M, Russ BE, Morey A, et al. CD4+ T help promotes influenza virus-specific CD8+ T cell memory by limiting metabolic dysfunction. Proc Natl Acad Sci U S A. 2019;116:4481–8.
Dhakal S, Lu F, Ghimire S, Renu S, Lakshmanappa YS, Hogshead BT, et al. Corn-derived alpha-D-glucan nanoparticles as adjuvant for intramuscular and intranasal immunization in pigs. Nanomed Nanotechnol Biol Med. 2019;16:226–35.
Hale JS, Youngblood B, Latner DR, Mohammed AUR, Ye L, Akondy RS, et al. Distinct memory CD4+ T cells with commitment to T follicular helper- and T helper 1-cell lineages are generated after acute viral infection. Immunity. 2013;38:805–17.
Mackay LK, Stock AT, Ma JZ, Jones CM, Kent SJ, Mueller SN, et al. Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation. Proc Natl Acad Sci U S A. 2012;109:7037–42.
Sridhar S, Begom S, Bermingham A, Hoschler K, Adamson W, Carman W, et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med. 2013;19:1305–12.
Wilkinson TM, Li CKF, Chui CSC, Huang AKY, Perkins M, Liebner JC, et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med. 2012;18:274–80.
Thomas PG, Keating R, Hulse-Post DJ, Doherty PC. Cell-mediated protection in influenza infection. Emerg Infect Dis. 2006;12:48–54.